4l4j
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
==About this Structure== | ==About this Structure== | ||
| - | [[4l4j]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | [[4l4j]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L4J OCA]. |
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:023872058</ref><references group="xtra"/><references/> | <ref group="xtra">PMID:023872058</ref><references group="xtra"/><references/> | ||
| - | [[Category: | + | [[Category: Human]] |
[[Category: Gillilang, G.]] | [[Category: Gillilang, G.]] | ||
[[Category: Malia, T.]] | [[Category: Malia, T.]] | ||
Revision as of 05:43, 22 January 2014
Contents |
Crystal structure of fc-fragment of human IgG2-Sigma antibody
Template:ABSTRACT PUBMED 23872058
Disease
[IGHG2_HUMAN] Recurrent infections associated with rare immunoglobulin isotypes deficiency.
About this Structure
4l4j is a 2 chain structure with sequence from Human. Full crystallographic information is available from OCA.
Reference
- Vafa O, Gilliland GL, Brezski RJ, Strake B, Wilkinson T, Lacy ER, Scallon B, Teplyakov A, Malia TJ, Strohl WR. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations. Methods. 2013 Jul 17. pii: S1046-2023(13)00247-8. doi:, 10.1016/j.ymeth.2013.06.035. PMID:23872058 doi:10.1016/j.ymeth.2013.06.035
